Globus pharyngeus and extraesophageal reflux: Simultaneous pH <4.0 and pH <5.0 analysis

Laryngoscope

Volumn 120, Issue 11, 2010, Pages 2160-2164

  Zeleník, Karol ^a   Matoušek, Petr ^a   Urban, Ondřej ^a   Schwarz, Pavel ^a   Stárek, Ivo ^b   Komínek, Pavel ^a  

^a UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Extraesophageal reflux; globus pharyngeus; pH monitoring, pepsin; weakly acid reflux

Indexed keywords

ACID; BIOLOGICAL MARKER;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLOBUS PHARYNGEUS; HUMAN; INFLAMMATION; INFORMATION PROCESSING; LARYNGOPHARYNGEAL REFLUX; MALE; PATHOLOGICAL REFLEX; PH MEASUREMENT; PRIORITY JOURNAL; THROAT DISEASE;

EID: 78349276881     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.21147     Document Type: Article

References (13)

1. Karkos PD, Wilson JA., The diagnosis and management of globus pharyngeus: our perspective from United Kingdom. Curr Opin Otolaryngol Head Neck Surg 2008; 16: 521-524.
2. Johnston N, Wells CW, Samuels TL, Blumin JH., Pepsin in nonacidic refluxate can damage hypopharyngeal epithelial cells. Ann Otol Rhinol Laryngol 2009; 118: 677-685.
3. Smit C, Tan J, Devriese P, Mathus-Vliegen L, Brandsen M, Schouwenburg P., Ambulatory pH measurements at the upper esophageal sphincter. Laryngoscope 1998; 108: 299-302.
4. Postma GN, Belafsky PC, Aviv JE, Koufman JA., Laryngopharyngeal reflux testing. Ear Nose Throat J 2002; 81: 14-18.
5. Reichel O, Issing WJ., Impact of different pH thresholds for 24-hour dual probe pH monitoring in patients with suspected laryngopharyngeal reflux. J Laryngol Otol 2008; 122: 485-489.
6. Johnston N, Dettmar PW, Bishwokarma B, Lively MO, Koufman JA., Activity/stability of human pepsin: implications for reflux attributed laryngeal disease. Laryngoscope 2007; 117: 1036-1039.
7. Reavis KM, Morris CD, Gopal DV, Hunter JG, Jobe BA., Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms. Ann Surg 2004; 239: 849-856.
8. Sato K, Umeno H, Chitose S, Nakashima T., Patterns of laryngopharyngeal and gastroesophageal reflux. J Laryngol Otol 2009; 123 (suppl S31): 48-47.
9. Jecker P, Schuon R, Morales C, Wohlfeil M, Rassouli S, Mann WJ., Determination of normal values of extraesophageal reflux in 24-h two-channel pH testing [in German]. HNO 2008; 56: 1040-1045.
10. Karkos PD, Benton J, Leong SC, et al. Trends in laryngopharyngeal reflux: a British ENT survey. Eur Arch Otorhinolaryngol 2007; 264: 513-517.
11. Karkos PD, Wilson JA., Empiric treatment of laryngopharyngeal reflux with proton pump inhibitors: a systematic review. Laryngoscope 2006; 116: 144-148.
12. McGlashan JA, Johnstone LM, Sykes J, Strugala V, Dettmar PW., The value of liquid alginate suspension (Gaviscon Advance) in the management of laryngopharyngeal reflux. Eur Arch Otorhinolaryngol 2009; 266: 243-251.
13. Weiner GJ, Tsukashima R, Kelly C, et al. Oropharyngeal pH monitoring for the detection of liquid and aerosolised supraesophageal gastric reflux. J Voice 2009; 23: 498-504.